ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

DXR Daxor Corporation

9,5527
-0,121 (-1,25%)
10 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Daxor Corporation DXR NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,121 -1,25% 9,5527 17:10:38
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
9,67 9,49 9,67 9,5527 9,6737
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/04/202409:00GLOBENew Studies Prove the Clinical Benefits of Daxor’s Blood..
15/04/202409:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
10/04/202409:00GLOBEDaxor Corporation Announces New Hospital Account at Leading..
01/04/202409:00GLOBEDaxor Corporation to Exhibit at the American College of..
25/03/202409:00GLOBEDaxor Corporation Acquires Volumex® and Megatope® From Its..
22/03/202409:00GLOBEDaxor Corporation to Hold Investor Call Discussing Fiscal..
18/03/202415:18GLOBEDaxor Corporation Reports Increase in NAV to $7.08 Per Share..
11/03/202409:00GLOBEDaxor Announces Sales to Three New Hospitals Furthering..
08/03/202410:00GLOBEMulti-Center Study Presented by Duke at Heart Failure..
26/02/202410:00GLOBEDaxor Corporation to Exhibit at the Technology and Heart..
12/02/202410:00GLOBEDaxor Corporation Starts 2024 with Ongoing Growth in New..
07/02/202410:00GLOBEDaxor Corporation Closes Q4 2023 with Growth in New Sales to..
29/01/202410:00GLOBEDaxor Corporation to Exhibit at the Society of Nuclear..
16/01/202410:00GLOBEDaxor Corporation to Exhibit at the Society for Critical..
09/01/202410:00GLOBEDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME..
02/01/202410:30GLOBEDaxor Corporation Submits Dual 510(k)/CLIA-waiver..
13/11/202310:00GLOBENew Randomized Controlled Trial Demonstrates the Efficacy of..
09/11/202310:00GLOBEDaxor Corporation Awarded New Patent for Remote Monitoring..
13/10/202309:00GLOBEExpert Panelists Advocate Use of Daxor’s Technology to..
11/10/202309:00GLOBENew Data from Banner University Medicine Demonstrating..
04/10/202309:00GLOBEDaxor Corporation Awarded Support from the National..
27/09/202309:00GLOBEDaxor Corporation to Exhibit at the Heart Failure Society of..
26/09/202309:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
11/09/202313:00GLOBEDaxor Corporation Awarded $305K Grant from the National..
07/09/202310:15GLOBEDaxor Corporation to Present at the H.C. Wainwright 25th..
28/08/202317:15GLOBEDaxor Corporation CEO and President Michael Feldschuh..
28/08/202317:05GLOBEDaxor Corporation Reports a 20.64 Percent Increase in..
10/08/202309:00GLOBEJACC-HF Reports Successful Heart Failure Trial With Daxor..
12/07/202309:00GLOBEJACC-HF Study Compares Daxor’s BVA-100® Volume Metric to..
11/07/202309:00GLOBEDaxor Corporation Announces Further Acquisitions and..
05/07/202309:00GLOBEDaxor Corporation Awarded $1.1 Million Contract from the..
22/06/202317:15GLOBEDaxor Corporation Announces Partial Exercise of..
20/06/202309:00GLOBEDaxor Corporation to Showcase the Benefits of BVA-100®..
15/06/202309:00GLOBEDaxor Accelerates Blood Volume Analysis Adoption with the..
12/06/202309:00GLOBEDaxor Corporation to Participate in the Maxim Group Virtual..
25/05/202316:37GLOBEDaxor Corporation Announces Closing of $4.0 Million..
22/05/202309:30GLOBEDaxor Corporation Announces Pricing of $4.0 Million..
19/05/202317:53GLOBEDaxor Corporation Announces Proposed Underwritten Public..
18/05/202309:00GLOBENew Study Demonstrates Clinical Utility of Daxor’s Blood..

Seu Histórico Recente

Delayed Upgrade Clock